Literature DB >> 17081710

Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats.

Ming-Guang Li1, Wan-Liang Lu, Jian-Cheng Wang, Xuan Zhang, Xue-Qing Wang, Ai-Ping Zheng, Qiang Zhang.   

Abstract

The purpose of this work was to investigate distribution, transition, bioadhesion and release behaviors of insulin loaded pH-sensitive nanoparticles in the gut of rats, as well as the effects of viscosity agent on them. Insulin was labeled with fluorescein isothiocyanate (FITC). The FITC-insulin solution and FITC-insulin nanoparticle aqueous dispersions with or without hydropropylmethylcellulose (HPMC, 0.2%, 0.4%, or 0.8% (w/v)) were orally administered to rats, respectively. The amounts of FITC-insulin in both the lumen content and the intestinal mucosa were quantified by a spectrofluorimeter. The release profiles in the gut were plotted by the percentages of FITC-insulin released versus time. FITC-insulin nanoparticle aqueous dispersion showed similar stomach but lower intestine empty rates, and enhanced intestinal mucosa adhesion in comparison with FITC-insulin solution. Addition of the HPMC reduced the stomach and intestine empty rates, enhanced the adhesion of FITC-insulin to the intestine mucosa. The release of FITC-insulin from nanoparticles in the gut showed an S-shape profile, and addition of HPMC prolonged the release half-life from 0.77 to 1.51h. It was concluded that the behaviors of pH-sensitive nanoparticles tested in gastrointestinal tract of rats and the addition of HPMC were favorable to the absorption of the drug loaded.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081710     DOI: 10.1016/j.ijpharm.2006.08.040

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Bioengineering Bacterially Derived Immunomodulants: A Therapeutic Approach to Inflammatory Bowel Disease.

Authors:  Lina Herrera Estrada; Huixia Wu; Kevin Ling; Guikai Zhang; Ronen Sumagin; Charles A Parkos; Rheinallt M Jones; Julie A Champion; Andrew S Neish
Journal:  ACS Nano       Date:  2017-09-05       Impact factor: 15.881

Review 2.  pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.

Authors:  Lin Liu; WenDong Yao; YueFeng Rao; XiaoYang Lu; JianQing Gao
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.